Actavis Net Revenue Increases 59% to $2.779 Billion in Fourth Quarter 2013LEARN MORE>
Actavis Completes Forest Laboratories Acquisition
>Go!

Executive Leadership and Directors

Executive Leadership
Paul M. BisaroExecutive Chairman, Actavis plc
Brent L. SaundersCEO & President
Robert A. StewartPresident, Generics and Global Operations
Maria Teresa HiladoChief Financial Officer
Paul NavarrePresident, International Brands
Bill MeuryPresident, Branded Pharma
Philippe SchaisonPresident, Allergan Medical
Karen LingChief Human Resources Officer
Charles M. MayrChief Communications Officer
Bob BaileyChief Legal Officer
Jonathon L. KellermanGlobal Chief Compliance Officer
Alex KellyChief Integration Officer
Sigurd KirkCorporate Business Development
David Nicholson,Ph.D.Brand R&D
Sanjiv PatelChief Strategy Officer
Directors
Nesli Basgoz, M.D.Associate Chief for Clinical Affairs, Division of Infectious Diseases, Massachusetts General Hospital (MGH)
Paul M. BisaroExecutive Chairman, Actavis plc
James H. BloemSenior Vice President, Chief Financial Officer and Treasurer, Humana Inc.
Christopher W. BodineFormer President, Health Care Services for CVS Caremark Corporation
Christopher J. CoughlinFormer Executive Vice President and Chief Financial Officer, Tyco
Michael R. GallagherFormer Chief Executive Officer and Director of Playtex Products, Inc.
Catherine  M.  KlemaLead Independent Director – President, Nettleton Advisors LLC
Peter J. McDonnell, M.D.Director and William Holland Wilmer Professor of the Wilmer Eye Institute of the Johns Hopkins University School of Medicine
Patrick J. O’SullivanFormer Chief Executive Officer, LEO Pharma Ireland
Brent L. SaundersCEO & President, Actavis plc
Ronald R. TaylorPresident, Tamarack Bay LLC
Fred G. WeissManaging Director, FGW Associates, Inc.
ELECTRONIC ENROLLMENT